Interestingly, one melanoma which developed a novel NRAS non-hot-spot mutation p.(P140S) predicted by in silico approach to be benign also carried a pathogenic hot-spot KRAS mutation p.(G12C). This evidence concerns the gene KRAS and melanoma.